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Background-—Favorable levels of all readilymeasurablemajor cardiovascular disease risk factors (ie, low risk [LR]) are associatedwith
lower risks of cardiovascular diseasemorbidity andmortality. Data are not available on LR prevalence amongHispanic/Latino adults of
diverse ethnic backgrounds. This study aimed to describe the prevalence of a low cardiovascular disease risk profile among Hispanic/
Latino adults in the United States and to examine cross-sectional associations of LR with measures of acculturation.
Methods and Results-—The multicenter, prospective, population-based Hispanic Community Health Study/Study of Latinos
examined 16 415men andwomen aged 18 to 74 years at baseline (2008–2011) with diverseHispanic/Latino backgrounds. Analyses
involved 14 757 adults (mean age 41.3 years; 60.6% women). LR was defined using national guidelines for favorable levels of serum
cholesterol, blood pressure, and body mass index and by not having diabetes mellitus and not currently smoking. Age-adjusted LR
prevalence was low (8.4% overall; 5.1% for men, 11.2% for women) and varied by background (4.2% in men of Mexican heritage versus
15.0% in women of Cuban heritage). Lower acculturation (assessed using proxy measures) was significantly associated with higher
odds of a LR profile among women only: Age-adjusted odds ratios of having LR were 1.64 (95% CI 1.24–2.17) for foreign-born versus
US-born women and 1.96 (95% CI 1.49–2.58) for women residing in the United States <10 versus ≥10 years.
Conclusions-—Among diverse US Hispanic/Latino adults, the prevalence of a LR profile is low. Lower acculturation is associated
with higher odds of a LR profile among women but not men. Comprehensive public health strategies are needed to improve the
cardiovascular health of US Hispanic/Latino adults. ( J Am Heart Assoc. 2016;5:e003929 doi: 10.1161/JAHA.116.003929)
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C ardiovascular disease (CVD) is a leading cause ofmortality among Hispanic/Latino adults in the United
States. Although recent reports from the landmark Hispanic
Community Health Study/Study of Latinos (HCHS/SOL)
documented the substantial and pervasive burden of readily
measurable major adverse CVD risk factors, marked
variations in adverse CVD risk profiles among diverse
Hispanic/Latino persons have also been noted, potentially
related to their heterogeneous lifestyles, exposures, and
acculturation to US society.1
Large-scale prospective cohort studies of non-Hispanic/
Latino young adult and middle-aged men and women with
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decades of follow-up have demonstrated multiple beneficial
outcomes associated with favorable levels of all major CVD
risk factors (ie, low risk [LR]).2–7 LR status in young adulthood
or middle age is associated with markedly lower age-specific
CVD and total mortality rates, higher life expectancies, lower
health care costs, and better quality of life at older ages.2–7
The importance of population-wide LR status to overcome the
CVD epidemic is now widely accepted, with LR status forming
the basis of the ideal cardiovascular health construct
described in the American Heart Association (AHA) 2020
Impact Goal.8 According to national data, the prevalence of LR
was 8.2% among non-Hispanic white US adults (and 7.5%
overall) in 1999–2004.9
Previous studies included few Hispanic/Latino partici-
pants,2–7 and existing estimates of prevalence of LR status
among US Hispanics/Latino adults based on national survey
data are limited mostly to those of Mexican American
heritage.9 Furthermore, there are no data on associations of
low CVD risk status with acculturation among Hispanic/
Latino adults from diverse backgrounds. Comprehensive and
current data on the cardiovascular health of diverse US
Hispanic/Latino groups, including not only the well-known
burden of adverse risk but also the less-documented preva-
lence of favorable risk status, is critically important for the
development of tailored individual- and population-level
interventions to prevent future CVD in this rapidly growing
segment of the US population.
This paper describes the age-, sex-, and Hispanic/Latino
background–specific prevalence of LR profile among diverse
US Hispanic/Latino adults free of clinical CVD and examines
the associations of LR profile with measures of acculturation
using data from HCHS/SOL.
Methods
Study Design and Population
HCHS/SOL is a population-based cohort study designed to
examine risk and protective factors for chronic diseases
among US Hispanic/Latino adults and to quantify morbidity
and mortality prospectively. Details of the sampling methods
and design have been published.10,11 Briefly, between March
2008 and June 2011, 16 415 self-identified Hispanic/Latino
adults aged 18 to 74 years were recruited from randomly
selected households in 4 US communities (Bronx, NY;
Chicago, IL; Miami, FL; San Diego, CA), using a stratified
2-stage probability sample design.10 Participants included
adults with Cuban, Dominican, Mexican, Puerto Rican, and
Central and South American backgrounds. The study was
approved by the institutional review board at each center,
and written informed consent was obtained from all
participants.
Examination Methods
Participants were asked to fast and to refrain from smoking for
12 hours prior to the examination and to avoid vigorous
physical activity the morning of the visit. Information was
obtained using questionnaires on demographic factors, socioe-
conomic status, cigarette smoking, physical activity (moder-
ate/heavy intensity work and leisure activities in a typical
week), and medical history and the Short Acculturation Scale
for Hispanics (SASH),12 which includes social and language
subscales and proxy measures of acculturation (including
nativity, duration of residence in the United States, generational
status, language preference, and age at immigration). Partic-
ipants were instructed to bring all medications they had taken in
the past month.
Height was measured to the nearest centimeter and body
weight to the nearest 0.1 kg. Body mass index (BMI) was
computed as weight divided by height squared (kg/m2).
Following a 5-minute rest period, 3 seated blood pressure (BP)
measurements were obtained using an automatic sphygmo-
manometer; the second and third readings were averaged. Blood
samples were collected and shipped to a central laboratory for
analysis according to standardized protocols. Blind replicate
measurements were conducted for 5% of the samples. Details of
the quality control procedures implemented havebeendescribed
previously.11 Total serum cholesterol was measured using a
cholesterol oxidase enzymatic method, and high-density lipopro-
tein cholesterol was measured using a direct magnesium/
dextran sulfate method. Plasma glucose was measured using a
hexokinase enzymatic method (Roche Diagnostics Corp). Low-
density lipoprotein cholesterol was calculated using the Friede-
wald equation.13HemoglobinA1cwasmeasured using the Tosoh
G7 Automated HPLC Analyzer (Tosoh Bioscience Inc).
Definition of Risk Factors
Favorable levels of major CVD risk factors were defined based
on national guidelines.14–17 LR status was defined as having
all of the following factors: serum total cholesterol <200 mg/
dL and not taking cholesterol-lowering medication; systolic BP
<120 mm Hg, diastolic BP <80 mm Hg, and not taking
antihypertensive medication; BMI <25; not currently smoking;
and fasting glucose <100 mg/dL, hemoglobin A1c <5.7%, not
taking medication for diabetes mellitus, and no history of
diabetes mellitus.
Unfavorable or borderline risk factor levels were defined as
total cholesterol 200 to 239 mg/dL and not taking cholesterol-
lowering medications; systolic BP 121 to 139 mm Hg or
diastolic BP 81 to 89 mm Hg and not taking antihypertension
medication; fasting glucose 100 to 125.9 mg/dL or hemoglo-
bin A1c 5.7% to 6.4%, not taking medication for diabetes
mellitus, and no history of diabetes mellitus; and BMI 25.0 to
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29.9. Adverse CVD risk factors were defined as serum
cholesterol ≥240 mg/dL or taking cholesterol-lowering med-
ication; systolic BP ≥140 mm Hgor diastolic BP ≥90 mm Hg or
taking antihypertensive medication; BMI ≥30.0; fasting glucose
≥126 mg/dL, hemoglobin A1c ≥6.5%, or taking medication for
diabetes mellitus; and current cigarette smoking. Participants
not at LR were classified as having no adverse but ≥1
unfavorable or borderline risk factor, any single adverse risk
factor, or ≥2 adverse risk factors. Of note, smoking status was
dichotomized as not currently smoking (LR) versus current
smoking (adverse), consistent with both previous research on
low CVD risk profile3,6 and the AHA’s definition of cardiovas-
cular health metrics8 included in the ideal cardiovascular health
construct (designed to be simple and accessible by the public
and by health practitioners and to represent actionable items to
improve cardiovascular health). Participants classified as
having no adverse but ≥1 unfavorable or borderline risk factor
were, by definition, not current smokers.
Statistical Analyses
Reported values for mean, prevalence, and odds ratio were
weighted to adjust for sampling probability and nonre-
sponse.10,11 All analyses were conducted for men and women
separately. Age-adjusted LR prevalence was calculated by
Hispanic/Latino background for all participants and stratified
by age groups (18–44 years that is young adults, and
45–74 years that is middle-aged and older adults). Prevalence
of LR age-standardized to the 2010 US population was also
calculated. Logistic regression analyses, adjusted for age and
education, were used to examine associations of LR profile
(compared with not LR) with SASH scores and proxy
measures of acculturation. Analyses adjusted for family
history of coronary heart disease, income, health insurance
status, Hispanic/Latino background, and field center were
also conducted. Additional sensitivity analyses were con-
ducted to examine age-adjusted association of LR status with
measures of acculturation across strata of educational
attainment. Odds ratios with 95% CIs were computed.
Age-adjusted descriptive characteristicswere computed for LR
participants and comparedwith thosewith unfavorable or adverse
CVD risk status. Differences between groups were tested using
chi-square tests for categorical variables and F tests for contin-
uous variables. All analyses were performed using survey-specific
procedures to account for the multistage sampling design,
stratification, and clustering in SAS version 9.3 (SAS Institute)
and SUDAAN release 10.0.0 (Research Triangle Institute).
Exclusions
Of the 16 415 HCHS/SOL participants, 1658 were excluded
from these analyses for the following reasons: missing data
on total cholesterol (n=134), BMI (n=53), cigarette smoking
(n=35), or other covariates (n=481); electrocardiographic
evidence of past myocardial infarction (n=360); baseline age
≥75 years (n=5); or lack of self-identification as any of the 6
aforementioned Hispanic/Latino backgrounds (n=590). Con-
sequently, these analyses included data from 14 757 partic-
ipants (5810 men and 8947 women).
Results
Characteristics of the Study Cohort
The mean age of the participants was 41.3 years, and 60.6%
were women. Overall, 32.7% of the sample had less than a
high school education, 49.8% were married or living with a
partner, and 71.2% had lived in the United States for
≥10 years. Spanish was the preferred language for the
majority of participants (76.5%), and 49.7% had some health
insurance (data not shown).
Prevalence of LR Status and Individual Favorable
Risk Factors
The prevalence of LR status by Hispanic/Latino background
is depicted for all participants in Table 1 and for men and
women in Figure — Panel A and B, respectively. Among
HCHS/SOL participants, the overall age-adjusted prevalence
of LR status was 8.4%. Among both sexes and all Hispanic/
Latino backgrounds, LR status was uniformly rare. Among
men, overall age-adjusted LR prevalence was 5.1%, whereas
LR prevalence age-standardized to the 2010 US population
was 4.9% (Table 1); age-adjusted LR prevalence ranged from
4.2% (Mexican men) to 7.2% (Central American men) (Table 1
and Figure — Panel A). Adjustment for educational attainment,
duration of residence in the United States, health insurance
status (Table 1), or language preference (data not shown) did
not appreciably alter the findings. Among men aged 18 to
44 years, LR prevalence averaged 8.1% overall and ranged
from 7.2% (Mexican) to 10.7% (South American); among men
aged 45 to 74 years, LR prevalence averaged 1.4% (range
0.6–1.6%) (Table 2) (Table S1 provides the numbers of
participants used to calculate weighted prevalence in
Table 2).
Among women, age-adjusted LR prevalence was also
uniformly low overall (11.2%), whereas age-standardized
prevalence was 10.2% (Table 1). Age-adjusted LR prevalence
ranged from 7.3% (Puerto Rican women) to 15.0% (Cuban
women). Adjustment for educational attainment did not alter
the findings. LR prevalence among women aged 18 to 44
years ranged from 10.0% (Puerto Rican women) to 23.3%
(Cuban women), whereas among those aged 45 to 74 years,
LR prevalence ranged from 0.3% to 1.8% (Table 2).
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Lack of current smoking was the most predominant
favorable risk factor among both men (74.1%) and women
(83.9%). Slightly more than half of men (51.3%) also had
favorable serum cholesterol levels, and a sizeable propor-
tion of women had ideal glucose levels (59.8%), ideal BP
(58.9%), and ideal serum cholesterol levels (54.7%), with no
medication use for any of these risk factors; however, less
than a fourth of men and women had a favorable BMI. Men
with Mexican backgrounds had the lowest rates of favor-
able levels of serum glucose, and BMI and those of Puerto
Rican background the lowest rates of not currently
smoking. Among women, those with Puerto Rican back-
grounds had the lowest rates of favorable BP levels, BMI,
and not currently smoking (Table 3).
Rates of individual favorable risk factors differed between
men and women, although these sex differences varied across
age strata. Prevalence of favorable serum cholesterol levels
was 10.8 percentage points higher for women aged 18 to
44 years compared with men of the same age range.
Conversely, among those aged 45 to 74 years, prevalence
of favorable serum cholesterol levels was 9.14 percentage
points lower in women compared with men. Findings were
Figure. Age-adjusted prevalence of cardiovascular disease risk profiles by Hispanic/Latino background in
men (A) and in women (B). Risk profile details are described under “Definition of Risk Factors.” All values
were weighted for survey design and nonresponse and adjusted for age. BMI indicates body mass index; BP,
blood pressure; LR, low risk; RF, risk factor.
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similar for favorable BMI levels, although the magnitudes of
the sex differences in LR prevalence in each age strata were
lower (4.79 percentage points higher for women versus men
aged 18–44 years and 3.31 percentage points lower for
women versus men aged 45–74 years). Rates of no current
smoking, ideal glucose levels, and particularly ideal BP levels
were markedly higher in women aged 18 to 44 years (about
11–28 percentage points higher) compared with men in the
same age range. Although rates of these favorable risk factors
were also higher among women (versus men) aged 45 to 74
years (by about 3–8 percentage points), the magnitude of
differences was much lower (data not shown).
Association of LR Status With Measures of
Acculturation
Among women, being less acculturated was positively
associated with having a LR profile versus not (ie, all others)
(Table 4). In age-adjusted analyses, for example, women who
were foreign born (versus US born), who had resided in the
United States <10 years (versus ≥10 years; among all
participants), and who preferred the use of Spanish to
English had 1.64, 1.96, and 1.54 times higher odds,
respectively, of being LR. Women with SASH language
subscale scores <3 versus ≥3 (ie, lower versus higher
acculturation) had 1.58 times higher odds of being LR
compared with not LR. In contrast, the odds of being LR did
not differ by levels of SASH social subscale scores. Among
men, no significant associations were found between SASH
scores or proxy measures of acculturation and LR prevalence
(Table 4). Analyses adjusted for family history of coronary
heart disease and for Hispanic/Latino background, health
insurance status, and field center yielded similar results (data
not shown). Additional sensitivity analyses examining the
age-adjusted association of LR status with measures of
acculturation across educational attainment strata revealed
no significant associations among men. Although associa-
tions between measures of acculturation and LR status
differed across strata of educational attainment for women,
effect estimates were unstable, given the small numbers in
the cells (data not shown).
Characteristics of LR Participants Compared With
Others
Tables 5 and 6 provide age-adjusted demographic, socioeco-
nomic, and sociocultural characteristics of Hispanic/Latino
men and women across CVD risk groups. LR men and women
were significantly younger than others. After adjustment for
age, LR adults had the highest mean educational attainment,
with differences across groups significant for women but not
for men. In addition, the proportion of participants with an
annual family income <$20 000 was lowest among LR men
and women compared with others, with significant differences
for women.
Among women, those who were LR were, in general, less
acculturated than others. LR women, for example, had the
lowest age-adjusted rates of being US born and of having
resided in the United States for ≥10 years compared with
others (P<0.0001). Foreign-born LR women also had the
highest mean age at immigration (27.6 versus 24.5 years
for those with LR and with ≥2 adverse risk factors,
respectively; P=0.0003). In contrast, among men, those
who were LR were more acculturated; they were least likely
to prefer the use of Spanish compared with others and had
among the highest proportions of those who were US born
or who had resided in the United States for ≥10 years in
age-adjusted analyses. Rates of health insurance were higher
among LR men compared with others (59.9%; P=0.0102);
conversely, among women, the highest rates of health
insurance were reported by those who had ≥2 adverse risk
factors (55.9%; P=0.0009).
Table 2. Age-Stratified Prevalence of Low CVD Risk Status by Sex and Hispanic/Latino Background
Age Group, y
Prevalence of Low-Risk Status*†
All, n (%) Cuban, n (%) Dominican, n (%) Mexican, n (%)
Puerto Rican,
n (%)
Central American,
n (%)
South American,
n (%)
Men
18–44 202 (8.1) 26 (7.3) 16 (8.0) 73 (7.2) 37 (10.2) 30 (9.4) 20 (10.7)
45–74 34 (1.4) 7 (0.6) 2 (1.0) 10 (1.5) 7 (1.6) 5 (1.3) 3 (0.9)
Women
18–44 550 (17.9) 74 (23.3) 67 (18.5) 258 (17.9) 44 (10.0) 65 (17.2) 42 (21.8)
45–74 73 (1.2) 7 (1.0) 8 (1.5) 38 (1.8) 5 (0.3) 7 (0.9) 8 (1.5)
CVD indicates cardiovascular disease.
*All values (except n) were weighted for survey design and nonresponse.
†Low-risk status is described under “Definition of Risk Factors.”
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Tables 7 and 8 provide the prevalence and mean levels of
CVD risk factors by CVD risk status for men and women,
respectively.
Unfavorable or Borderline Risk Status
Age-adjusted prevalence of unfavorable or borderline risk
(ie, neither LR nor high risk) was 24.9% and 24.1% among men
and women, respectively, and ranged from 20.1% (Puerto
Rican background) to 36.3% (South American background)
among men (Figure — Panel A) and from 14.6% (Puerto Rican
background) to 33.1% (South American background) among
women (Figure — Panel B). The majority of participants with
unfavorable risk status were overweight (80.2% for both men
and women). Furthermore, about 51.7% of men and 26.5% of
women with unfavorable risk status had unfavorable BP levels;
38.2% and 40.6%, respectively, had unfavorable cholesterol
levels; and 38.6% and 27.5%, respectively, had unfavorable
glucose levels (data not shown).
Men characterized as being at unfavorable risk were, in
general, less acculturated than other men. Overall, 81.6% of
men at unfavorable risk reported preferring Spanish (versus
English), and 66.5% had lived in the United States for
≥10 years compared with 71.7% and 76.8%, respectively, of
men with ≥2 adverse risk factors (P<0.0001) (Table 5).
Discussion
Among the adult Hispanic/Latino men and women who
participated in HCHS/SOL, age-adjusted prevalence of LR
status was low, especially among men (5.1% of men and
11.2% of women). LR prevalence varied by Hispanic/Latino
background. Among men, LR prevalence was highest among
those with Central American backgrounds and lowest among
those with Mexican and Dominican backgrounds, although the
magnitude of variation was small (ie, only a 3–percentage
point difference between the highest- and lowest-prevalence
groups). Among women, LR prevalence showed somewhat
greater variation and was highest among those with Cuban
and South American backgrounds and lowest among those
with Puerto Rican backgrounds. On average, LR adults were
younger and more educated (particularly women) compared
with others. Being less acculturated was consistently asso-
ciated with a LR profile among women, but no significant
associations were seen among men. Conversely, prevalence
of unfavorable or borderline CVD risk was relatively high and
correlated with less acculturation among men only.
Sex differences in both the prevalence of CVD risk factors
and the timing of onset of CVD have been extensively
described,18–20 and among women, worsening of CVD risk
has been noted with menopause.20,21 Consequently, it is not
surprising that in the current study, differences in LR
prevalence between men and women were observed primarily
at younger ages (8.1% of men and 17.9% of women), with
similar low prevalence of LR among those aged 45 to 74 years
(1.4% of men and 1.2% of women). Examination of individual
favorable risk factors across age–sex strata suggested that
changes in lipid profiles (and, to a smaller extent, BMI) may
underlie changes in patterns of sex differences in LR
prevalence with age. These findings may be explained by
Table 4. Adjusted Associations of LR Status With Measures
of Acculturation by Sex
Measure of
Acculturation†
LR (Reference: Not LR)*
Age-Adjusted‡
OR (95% CI)
Age- and Education-
Adjusted‡
OR (95% CI)
Men
Foreign born 1.03 (0.73–1.46) 1.09 (0.77–1.54)
Residence in
US <10 years
0.87 (0.61–1.23) 0.88 (0.62–1.25)
Prefer Spanish 0.84 (0.57–1.23) 0.88 (0.61–1.29)
Age at
immigration, y
0.99 (0.96–1.01) 0.99 (0.96–1.01)
Age ≥25 years at
immigration
1.19 (0.65–2.19) 1.14 (0.62–2.09)
SASH language
subscale
(low; ie, <3)
0.83 (0.57–1.21) 0.87 (0.60–1.27)
SASH social
subscale
(low; ie, <3)
0.77 (0.52–1.15) 0.79 (0.53–1.19)
Women
Foreign born 1.64 (1.24–2.17) 1.69 (1.28–2.24)
Residence in
US <10 years
1.96 (1.49–2.58) 2.01 (1.54–2.63)
Prefer Spanish 1.54 (1.14–2.08) 1.71 (1.27–2.30)
Age at
immigration, y
1.05 (1.02–1.07) 1.05 (1.02–1.07)
Age ≥25 years at
immigration
2.04 (1.39–2.99) 1.88 (1.27–2.78)
SASH language
subscale
(low; ie, <3)
1.58 (1.19–2.11) 1.71 (1.29–2.28)
SASH social
subscale
(low; ie, <3)
1.27 (0.92–1.76) 1.34 (0.98–1.83)
LR indicates low risk; OR, odds ratio; SASH, Short Acculturation Scale for Hispanics; US,
United States.
*LR status is described under “Definition of Risk Factors.”
†Models constructed comparing foreign-born vs US-born participants, residence in US
<10 years vs ≥10 years, Spanish language preference vs English, and SASH scores <3
vs ≥3. Variables were entered into the model individually.
‡All values (except n) were weighted for survey design and nonresponse.
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the cardioprotective effects of endogenous estrogen prior to
menopause and the unfavorable effect of menopause on lipid
metabolism in women.21,22
These findings on LR prevalence among diverse US
Hispanic/Latino adults extend the findings of previous studies
on adverse risk factors among US Hispanic/Latino adults23–27
and our earlier report on adverse CVD risk factors in the
HCHS/SOL cohort.1 Previous large-scale prospective studies
have demonstrated multiple beneficial outcomes of low CVD
risk status2–7 that may exceed what would be expected from
simply the absence of high CVD risk. Increasing the propor-
tion of LR adults may yield additional health benefits beyond
effective CVD prevention. Documentation of LR prevalence
among this growing segment of US society is necessary to
accurately estimate the magnitude of improvement in risk and
future burden of disease among Hispanic/Latino adults with
unfavorable or adverse levels of CVD risk factors.
National studies that have reported LR prevalence in the US
Hispanic/Latino population included primarily Mexican Amer-
ican adults. Age-adjusted LR prevalence (using a definition
similar to ours) was 5.3% in 1999–2004 among Mexican
American adults from the National Health and Nutrition
Examination Survey (NHANES) compared with 8.2% for non-
Hispanic white adults (7.5% for the US population overall).9 An
analysis of NHANES 2003–2008 data (using the AHA Life’s
Simple 7 definition) found that <1% of adults in each major US
racial/ethnic group (including Mexican American adults)
had ideal levels of all 7 cardiovascular health components (5
major CVD risk factors plus physical activity and healthy diet).28
The current findings of variation in LR prevalence across
Hispanic/Latino backgrounds challenge the validity of extend-
ing findings based on data solely from Mexican American
adults to the wider US Hispanic/Latino population. In the
current study, men with Dominican and Mexican backgrounds
had the lowest LR prevalence, whereas among women, those
with Puerto Rican backgrounds had the lowest LR prevalence.
Men with Mexican backgrounds and women with Puerto Rican
backgrounds had the lowest rates of multiple favorable risk
factors, explaining the particularly low prevalence of LR status
in these groups; however, differences in LR prevalence by
background were small, particularly among men, as was the
prevalence of LR overall.
Although some previous studies have suggested that
foreign-born Mexican American adults may have more favor-
able risk status compared with those who were US born,29,30
this finding has not been observed consistently.31 Kershaw
et al reported that foreign-born Mexican Americans adults
had almost 3 times higher odds of being LR compared with
US-born Mexican American adults.29 Moreover, compared
with US-born Mexican American adults, the odds of being LR
were >4 times higher among foreign-born Mexican American
adults who had resided in the United States for <10 years. InT
ab
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contrast, foreign-born Mexican American adults with
≥10 years of residence in the United States had 1.61 times
higher odds of being LR compared with US-born Mexican
American adults.29 The current findings on the association of
measures of acculturation with LR status are consistent with
the “healthy migrant hypothesis” (ie, that persons who choose
to migrate to a different country are selectively healthier than
nonmigrants),32 although some studies have found only weak
evidence to support this hypothesis.31
Acculturation is a multifaceted process that has been
shown to exert parallel effects that may be both detrimental
(ie, adoption of Western lifestyles) and beneficial (improved
socioeconomic status and access to care). The current
findings also suggest that the complex effects of acculturation
may differ by sex or that as yet unmeasured factors
associated with retaining Hispanic culture may also be
associated with health benefits among women only. In
addition, it is possible that the relatively higher LR prevalence
seen among some Hispanic/Latino backgrounds (eg, Cuban
and South American women) in HCHS/SOL may, to some
extent, be a reflection of the comparatively lower rates of
acculturation experienced by these groups.1 For example, the
proportion of HCHS/SOL participants who lived in the United
States for >10 years was lowest among those with Cuban
backgrounds (45.1%), followed by those with South American
backgrounds (53.9%).1 Those with Cuban and South American
backgrounds also included the highest proportions of adults
who reported preferring the use of Spanish to English.1 Given
the cross-sectional nature of these analyses, it is also
possible that variations seen across backgrounds are a
reflection of differences in immigration patterns over time.
Adjustment for proxy measures of acculturation such as
duration of residence in the United States and language
preference did not alter the findings. Adding to the complexity
of these findings, although women with Cuban backgrounds
had among the highest prevalence of LR status, they also had
the highest rates of having ≥2 adverse risk factors. This result
is consistent with our current findings that although this
group had the highest rate of ideal BMI and among the highest
rates of ideal glucose status, these participants also experi-
enced high rates of adverse risk factors such as cigarette
smoking, hypertension, and hypercholesterolemia.1 Further
research is needed to shed light on specific aspects of diverse
Hispanic/Latino cultures that may exert a health-protective
effect and to characterize the effects of acculturation by sex
and ethnic background.
In light of the low rates of LR among Hispanic/Latino men
and women overall, it is important to note the sizeable
prevalence of unfavorable or borderline risk status: almost 1
in 4 Hispanic/Latino adult men and women overall (ranging
from 15% of Puerto Rican women to 36% in South
American men). These groups represent at-risk (but not yetTa
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high-risk) segments of the US Hispanic/Latino population that
could benefit from primary preventive efforts without neces-
sarily needing pharmaceutical intervention. These adults
present an expedient and urgent opportunity to increase the
proportion of the population at LR through timely implemen-
tation of interventions emphasizing overall healthy lifestyles
and nutritional hygiene. In contrast, these findings on rates of
LR and unfavorable risk status reveal a bleaker picture of CVD
health among Hispanic/Latino adults than reported earlier.
Among HCHS/SOL participants without any adverse CVD risk
factors,1 for example, a sizeable proportion did not have
favorable CVD risk profiles. Moreover, the current analyses
show that among the participant groups with the highest
prevalence of no adverse CVD risk factors, South American
men (19.4%) and women (30.4%),1 only 7% and 14%,
respectively, were LR. Consequently, the high prevalence of
unfavorable risk is a sobering indication of the possibility that
as the currently young Hispanic/Latino population ages, it
may be burdened by even higher rates of adverse CVD risk
profiles. The fact that almost half of men and more than half
of women at unfavorable risk reported having no health
insurance coverage underscores the importance of public
health initiatives to identify persons who are at risk of
developing adverse CVD risk factors.
The cross-sectional nature of the analyses is a limitation of
this study. Nevertheless, these findings are novel and of
public health importance. Although the different countries in
Central and South America have unique ethnic and cultural
Table 7. Prevalence and Mean Levels of CVD Risk Factors for Men by CVD Risk Profiles
CVD Risk Factors*
CVD Risk Status,† Mean or % (95% CI)
P ValueLR 0 RF 1 RF 2+ RF
Participants, n 236 1347 1977 2250
Total cholesterol, mg/dL 159.4 (155.1–163.7) 186.3 (184.0–188.7) 194.1 (191.6–196.6) 209.4 (206.1–212.8) <0.0001
LDL cholesterol, mg/dL 93.0 (89.2–96.9) 116.3 (114.2–118.4) 122.2 (120.0–124.3) 130.9 (127.8–134.1) <0.0001
HDL cholesterol, mg/dL 49.2 (47.3–51.2) 46.3 (45.5–47.0) 44.8 (44.1–45.4) 43.4 (42.6–44.1) <0.0001
Triglycerides, mg/dL 86.5 (77.2–95.9) 120.8 (114.3–127.3) 141.0 (135.3–146.8) 188.0 (177.7–198.2) <0.0001
Elevated triglycerides (%)‡ 9.8 (5.2–14.4) 22.3 (19.2–25.4) 32.3 (29.7–34.9) 50.6 (47.5–53.8) <0.0001
Systolic BP, mm Hg 114.6 (113.5–115.7) 120.6 (119.8–121.4) 122.1 (121.5–122.8) 129.1 (128.1–130.2) <0.0001
Diastolic BP, mm Hg 63.7 (62.5–64.9) 70.7 (70.0–71.4) 73.2 (72.6–73.7) 78.1 (77.3–78.9) <0.0001
BMI category (%)
Underweight 8.5 (4.5–12.5) 0.6 (0.1–1.1) 0.6 (0.2–1.0) 0.3 (0.1–0.6) 0.0001
Normal 91.5 (87.3–95.7) 23.3 (20.4–26.2) 22.4 (19.5–25.3) 8.1 (6.6–9.5) <0.0001
Overweight — 80.2 (77.2–83.1) 40.1 (37.4–42.8) 20.6 (18.0–23.2) <0.0001
Obese — — 36.9 (34.0–39.8) 71.0 (68.3–73.8) <0.0001
BMI 21.0 (20.6–21.5) 26.0 (25.8–26.2) 28.8 (28.5–29.2) 32.1 (31.8–32.4) <0.0001
Fasting glucose, mg/dL 93.7 (92.5–95.0) 96.5 (95.8–97.2) 98.8 (98.0–99.7) 117.5 (114.7–120.3) <0.0001
Smoking status (%)
Never smoker 87.2 (82.6–91.8) 73.9 (70.7–77.1) 46.5 (43.3–49.7) 35.1 (31.8–38.3) <0.0001
Former smoker 21.5 (17.1–25.9) 29.6 (26.6–32.7) 21.3 (19.3–23.3) 19.3 (16.8–21.8) <0.0001
Current smoker — — 32.2 (29.3–35.1) 45.7 (42.3–49.1) <0.0001
Waist/hip ratio 0.88 (0.87–0.89) 0.92 (0.92–0.93) 0.94 (0.94–0.95) 0.97 (0.97–0.98) <0.0001
Central obesity (%)§ 30.8 (25.0–36.6) 63.4 (59.9–67.0) 77.3 (74.6–80.0) 87.2 (85.3–89.1) <0.0001
Waist circumference, cm 80.2 (79.0–81.3) 91.1 (90.6–91.7) 98.1 (97.2–99.0) 106.2 (105.5–107.0) <0.0001
Waist circumference >102 cm — 5.9 (4.3–7.5) 34.5 (31.6–37.4) 62.9 (59.7–66.0) <0.0001
0 RF indicates, no adverse but ≥1 unfavorable risk factor; 1 RF, any single adverse risk factor; 2+ RF, ≥2 adverse risk factors; BMI, body mass index; BP, blood pressure; CVD,
cardiovascular disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LR, low risk; RF, risk factor; —, cannot be estimated.
*All values (except n) were weighted for survey design and nonresponse.
†Risk status details are described under “Definition of Risk Factors.” To convert total, LDL, and HDL cholesterol to mmol/L, multiply by 0.0259; to convert glucose to mmol/L, multiply by
0.0555.
‡Elevated triglyceride levels were defined as triglycerides ≥150 mg/dL.
§Central obesity was defined as waist/hip ratio ≥0.85 for women, ≥0.90 for men.
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characteristics, adults with Central and South American
backgrounds were grouped into these 2 broad categories.
Nevertheless, HCHS/SOL data allow a level of granularity in
examining the US Hispanic/Latino population by ethnic
background and other characteristics that was unavailable
previously. In addition, electrocardiograms may not always be
accurate in evaluating a history of previous myocardial
infarction because ECG changes may revert back to normal
over time in a sizeable proportion of persons with a history of
myocardial infarction.33,34 Nevertheless, it is unlikely that this
issue affected our estimates because adults with favorable
levels of all major CVD risk factors (without use of medica-
tions to control risk factor levels) are unlikely to have had a
previous myocardial infarction.
In conclusion, these findings demonstrate the low preva-
lence of favorable CVD risk profile among all major US
Hispanic/Latino groups and the urgent need for compre-
hensive public health interventions and policies to lower
CVD risk in this growing population. Further research is also
needed to understand the mechanisms underlying the
complex effects of acculturation on diverse Hispanic/Latino
men and women.
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Table 8. Prevalence and Mean Levels of CVD Risk Factors for Women by CVD Risk Profiles
CVD Risk Factors*
CVD Risk Status,† Mean or % (95% CI)
P ValueLR 0 RF 1 RF 2+ RF
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Total cholesterol, mg/dL 170.4 (168.0–172.9) 190.4 (188.4–192.4) 193.7 (191.9–195.6) 205.0 (202.6–207.5) <0.0001
LDL cholesterol, mg/dL 96.7 (94.5–98.9) 115.2 (113.5–116.8) 119.2 (117.6–120.8) 128.1 (125.9–130.2) <0.0001
HDL cholesterol, mg/dL 58.6 (57.2–60.0) 54.5 (53.6–55.4) 50.8 (50.1–51.5) 48.3 (47.6–49.1) <0.0001
Triglycerides, mg/dL 76.0 (72.7–79.3) 103.9 (100.5–107.2) 118.8 (115.3–122.3) 144.6 (139.5–149.8) <0.0001
Elevated triglycerides (%)‡ 6.2 (4.4–8.0) 15.5 (13.2–17.9) 22.6 (20.5–24.7) 36.6 (33.8–39.3) <0.0001
Systolic BP, mm Hg 110.9 (109.8–112.0) 112.9 (112.2–113.7) 114.3 (113.7–114.8) 122.6 (121.6–123.6) <0.0001
Diastolic BP, mm Hg 63.4 (62.6–64.1) 67.8 (67.2–68.4) 70.9 (70.4–71.4) 75.5 (74.8–76.2) <0.0001
BMI category (%)
Underweight 7.9 (4.9–10.9) 0.2 (0.0–0.5) 1.2 (0.4–2.0) 0.5 (0.1–0.9) <0.0001
Normal 94.1 (90.9–97.4) 22.5 (19.7–25.2) 14.8 (12.9–16.7) 5.1 (3.7–6.5) <0.0001
Overweight — 80.2 (77.4–82.9) 27.6 (25.4–29.7) 15.4 (13.3–17.5) <0.0001
Obese — — 56.4 (53.9–59.0) 79.0 (76.6–81.4) <0.0001
BMI 20.9 (20.6–21.2) 26.1 (25.9–26.3) 30.9 (30.6–31.3) 34.3 (33.8–34.7) <0.0001
Fasting glucose, mg/dL 89.8 (88.8–90.9) 91.2 (90.7–91.8) 94.7 (93.5–96.0) 113.2 (110.4–115.9) <0.0001
Smoking status (%)
Never smoker 96.1 (92.7–99.5) 90.5 (88.2–92.7) 68.1 (65.5–70.7) 51.4 (48.3–54.4) <0.0001
Former smoker 12.0 (8.9–15.1) 12.0 (9.9–14.2) 14.0 (12.4–15.6) 11.3 (9.5–13.0) 0.1196
Current smoker — — 17.9 (15.8–20.0) 37.4 (34.3–40.4) <0.0001
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Waist circumference, cm 77.9 (77.2–78.7) 88.8 (88.1–89.5) 98.7 (98.0–99.4) 106.0 (105.1–106.9) <0.0001
Waist circumference >88 cm 13.2 (9.8–16.6) 61.0 (57.7–64.2) 81.3 (79.3–83.4) 91.6 (89.6–93.6) <0.0001
0 RF indicates, no adverse but ≥1 unfavorable risk factor; 1 RF, any single adverse risk factor; 2+ RF, ≥2 adverse risk factors; BMI, body mass index; BP, blood pressure; CVD,
cardiovascular disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LR, low risk; RF, risk factor; —, cannot be estimated.
*All values (except n) were weighted for survey design and nonresponse.
†Risk status details are described under “Definition of Risk Factors.” To convert total, LDL, and HDL cholesterol to mmol/L, multiply by 0.0259; to convert glucose to mmol/L, multiply by
0.0555.
‡Elevated triglyceride levels were defined as triglycerides ≥150 mg/dL.
§Central obesity was defined as waist/hip ratio ≥0.85 for women, ≥0.90 for men.
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Table S1. Unweighted Cell Counts Corresponding to Weighted Prevalence in Table 2 
(Age-Stratified Prevalence of LR Status by Sex and Hispanic/Latino Background) 
 Hispanic/Latino Background 
Age Group ALL Cuban Dominican Mexican 
Puerto 
Rican 
Central 
American 
South 
American 
 Men 
18-44 2553 349 204 1102 383 333 182 
45-74 3257 691 269 1134 636 296 231 
 Women 
18-44 3444 384 376 1594 467 407 216 
45-74 5503 814 520 2205 995 588 381 
 
